Tomohiro Anzai
COO and Managing Partner at Fast Track Initiative- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Fast Track Initiative
-
United States
-
Venture Capital and Private Equity Principals
-
1 - 100 Employee
-
COO and Managing Partner
-
Jan 2006 - 18 years
Fast Track Initiative (FTI) is a Tokyo-based venture capital firm with a focus on investment in global Biotech and Healthtech start-ups. FTI has over 18 years of experience in venture investment with a successful track record and has $200m in assets of FTI Funds under management. Tomo is currently on the board of directors of several biotech companies including Braizon Therapeutics, NB Health Laboratory, PuREC, A10Lab and Modulus Discovery.
-
-
-
-
Co-Founder and Director
-
Dec 2015 - Aug 2020
Tokyo, Japan Merged with NanoCarrier Co.,Ltd. (4571:Tokyo)
-
-
-
Modalis Therapeutics
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Board Member
-
Oct 2017 - Dec 2019
Tokyo, Japan IPOed on Tokyo Stock Exchange Mothers (4883)
-
-
-
The University of Tokyo
-
Japan
-
Research Services
-
700 & Above Employee
-
Project Associate Professor
-
Oct 2008 - Mar 2018
Tokyo, Japan Project Associate Professor of Translational Research Initiative, the University of Tokyo. Tomo played a role as a project manager of Translational Research Projects at the University of Tokyo and was involved in the industry-academia collaboration projects.
-
-
-
Cabinet Office, Government of Japan
-
Japan
-
Public Policy Offices
-
1 - 100 Employee
-
Part-time member
-
Oct 2012 - Dec 2014
Tokyo, Japan A member of Medical Innovation Office, Cabinet Office, Government of Japan, involved in the establishment of Government Strategy for promoting Medical Innovation.
-
-
-
-
Co-Founder and Director
-
Jul 2006 - Sep 2013
Tokyo, Japan Acquired by Carna Biosciences Inc. (4572:Tokyo)
-
-
-
Arthur D. Little
-
Belgium
-
Business Consulting and Services
-
700 & Above Employee
-
Analyst
-
Apr 2004 - Dec 2005
-
-
Education
-
Massachusetts Institute of Technology
Advanced Management Program (AMP) -
The University of Tokyo
Ph.D., Molecular Biology